Sublicense Grant. Cellscript hereby grants to Company and Company hereby accepts from Cellscript a worldwide, non-exclusive sublicense under the Patent Rights during the Term to make, have made, import, use, offer for sale, sell and/or have sold Licensed Products according to the terms and conditions herein: (1) in Field of Use B for all uses in the In Vivo Field of Use, including: (a) all therapeutic and prophylactic uses in humans; (b) all non-therapeutic and non-prophylactic uses in humans; and (c) all uses, including therapeutic and prophylactic uses (e.g., Veterinary Products), in non-human animals; and (2) in Field of Use A for internal research and screening uses, including [***], including for the Fields of Use in (1)(a) through (1)(c); ((1) and (2) collectively, the “Sublicensed Fields of Use”), as all said terms are defined in Sections 1.2 and 6.1 herein (the “Sublicense”). The Sublicense includes the right for Company to grant sublicenses to its affiliates and Third Parties for all or any part of the rights and fields of use granted to Company, under terms that are consistent with this Agreement. No other rights or licenses are granted by Cellscript to Company under this Agreement; [***].
Appears in 3 contracts
Samples: Patent Sublicense Agreement (Moderna, Inc.), Patent Sublicense Agreement (Moderna, Inc.), Patent Sublicense Agreement (Moderna, Inc.)
Sublicense Grant. Cellscript hereby grants to Company and Company hereby accepts from Cellscript a worldwide, non-exclusive sublicense under the Patent Rights during the Term to make, have made, import, use, offer for sale, sell and/or have sold Licensed Products according to the terms and conditions herein: (1) in Field of Use B for all uses in the In Vivo Field of Use, including: (a) all therapeutic and prophylactic uses in humans; (b) all non-therapeutic and non-prophylactic uses in humans; and (c) all uses, including therapeutic and prophylactic uses (e.g., Veterinary Products), in non-human animals; and (2) in Field of Use A for internal for: research and screening uses, including [***]pre-clinical research and screening comprising ex vivo uses in human or non-human animal cells and in vivo uses in animals that pertain to and support research, including development, manufacture, regulatory approval and commercialization of Licensed Products for use in humans and non-human animals in the Fields In Vivo Field of Use in (1)(a) through (1)(c); (, as all Fields of Use in (1) and (2) (collectively, the “Sublicensed Fields of Use”), ) and as all said other terms which are not defined in this Section 1.1 are defined in Sections 1.2 and 6.1 herein (the “Sublicense”). The Sublicense includes the right for Company to grant sublicenses to its affiliates and Third Parties for all or any part of the rights and fields of use granted to Company, under terms that are consistent with this Agreement. No other rights or licenses are granted by Cellscript to Company under this Agreement; hereunder by Cellscript. [***].
Appears in 3 contracts
Samples: Patent Sublicense Agreement, Patent Sublicense Agreement (BioNTech SE), Patent Sublicense Agreement (BioNTech SE)